Real Estate Investment Trusts
Sabra Health Care REIT, Inc. (SBRA) stock: what's happening now, every material event decoded in plain English, P/E and valuation, analyst ratings, and insider buying and selling.
AllSight quality score: 32/100 — a percentile rank of Sabra Health Care REIT, Inc.’s fundamentals against Finance & Real Estate peers.
Is Sabra Health Care REIT, Inc. overvalued? P/E looks fair vs its 5-year range; P/S looks fair vs its 5-year range; EV/EBITDA looks overvalued vs its 5-year range; P/B looks overvalued vs its 5-year range.
Consensus: Hold from 29 analysts (Buy 11 · Hold 16 · Sell 2).
Average price target: $21.86 (+7.4% vs $20.35); range $20–$23.
Wall Street analyst consensus, shown as context — not an AllSight view.
Open-market buys: 2 · Open-market sells: 2 · Net: −$463K
Discretionary open-market purchases are the signal; grants, option exercises and Rule 10b5-1 scheduled trades are context, not counted in the balance. Facts only — not a recommendation. Source: SEC Form 4 filings on EDGAR.
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!